Breaking News Instant updates and real-time market news.

SDRL

Seadrill

$0.43

0.0145 (3.47%)

, I

Intelsat

$15.81

-0.12 (-0.75%)

08:45
06/14/18
06/14
08:45
06/14/18
08:45

Largest borrow rate increases among liquid names

Latest data shows the largest indicative borrow rate increases among liquid option names include: Seadrill (SDRL) 273.25% +14.97, Intelsat (I) 2.62% +0.09, AstraZeneca (AZN) 0.41% +0.08, GameStop (GME) 13.45% +0.03, Goldcorp (GG) 0.42% +0.03, Consumer Staples Sector SPDR (XLP) 0.54% +0.03, and Deutsche Bank (DB) 0.73% +0.01.

SDRL

Seadrill

$0.43

0.0145 (3.47%)

I

Intelsat

$15.81

-0.12 (-0.75%)

AZN

AstraZeneca

$36.18

0.01 (0.03%)

GME

GameStop

$13.34

-0.71 (-5.05%)

GG

Goldcorp

$14.19

-0.055 (-0.39%)

XLP

Consumer Staples Sector SPDR

$51.17

-0.175 (-0.34%)

DB

Deutsche Bank

$11.38

-0.025 (-0.22%)

  • 15

    Jun

  • 19

    Jun

  • 26

    Jun

  • 28

    Jun

  • 02

    Jul

  • 12

    Jun

SDRL Seadrill
$0.43

0.0145 (3.47%)

06/01/18
GHSC
06/01/18
UPGRADE
Target $18
GHSC
Buy
Ship Finance upgraded to Buy from Neutral at Seaport Global
Seaport Global analyst Magnus Fyhr upgraded Ship Finance (SFL) to Buy with a $18 price target saying risk/reward is increasingly attractive with several potential catalysts developing over the next few months, combined with the Seadrill (SDRL) restructuring already reflected in estimates. Fyhr said the company has ample dry powder to pursue accretive acquisitions and the current backlog provides cash flow visibility and dividend support.
I Intelsat
$15.81

-0.12 (-0.75%)

06/01/18
MSCO
06/01/18
NO CHANGE
Target $6
MSCO
Underweight
Intelsat price target raised to $6 from $1 at Morgan Stanley
Morgan Stanley analyst Simon Flannery noted that at a recent tower show FCC Chairman Ajit Pai announced his intention to introduce a C-band Notice of Proposed Rulemaking at the Commission's July 12 meeting, adding that the agenda for that meeting is expected June 21. While Flannery expects the FCC will be generally supportive of the joint spectrum sharing proposal being made by Intelsat (I) and Intel (INTC), he said "the devil is in the details" and that the C-band opportunity does not displace the secular pressures on Intelsat's organic business. Flannery is raising his Intelsat valuation to reflect the increased likelihood of spectrum monetization and increased his price target on the stock to $6 from $1, but he maintains an Underweight rating on the stock given the ongoing pressures in the satellite business.
03/01/18
JPMS
03/01/18
UPGRADE
JPMS
Neutral
Intelsat upgraded to Neutral from Underweight at JPMorgan
JPMorgan analyst Philip Cusick upgraded Intelsat to Neutral saying favorable newsflow is likely to continue as the company's plan to sell C-band spectrum looks viable.
11/01/17
UBSW
11/01/17
DOWNGRADE
Target $3
UBSW
Sell
Intelsat downgraded to Sell from Neutral at UBS
UBS analyst Batya Levi downgraded Intelsat to Sell with a price target of $3.00. The analyst views consensus estimates as too optimistic following management's "cautious commentary" on the Q3 earnings call. Pricing pressure continues and the EPIC fleet is ramping slower than anticipated, Levi tells investors in a post-earnings research note.
10/26/17
RBCM
10/26/17
DOWNGRADE
RBCM
Sector Perform
Intelsat downgraded to Sector Perform from Outperform at RBC Capital
AZN AstraZeneca
$36.18

0.01 (0.03%)

06/13/18
MSCO
06/13/18
NO CHANGE
MSCO
HHS 'smoke signals' worth noting for drugmakers, says Morgan Stanley
After HHS Secretary Alex Azar spoke at a two-hour Senate hearing, Morgan Stanley analyst David Risinger noted that Azar suggested that U.S. drug pricing needs to move to a system without rebates and said payments from drugmakers to PBMs should be eliminated. In listing four HHS actions that could hurt manufacturers, Risinger pointed out that Azar said he is interested in removing 100% cap on Medicaid rebates; he would like to adjust the Part D protected drug classes so that plans can extract rebates from manufacturers; HHS wants to require manufacturers to disclose drug list prices in TV ads; and HHS is focused on transitioning Part B to lower-priced private sector management. In summary, the analyst said that for drugmakers there was "no fire, but smoke signals worth noting." Publicly traded large-cap drugmakers include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY).
06/01/18
ROTH
06/01/18
NO CHANGE
Target $400
ROTH
Buy
Roth Capital ups Madrigal price target to $400, examines possible M&A scenarios
Roth Capital analyst Yasmeen Rahimi noted that Madrigal Pharmaceuticals' (MDGL) "impressive" NASH resolution results published yesterday resulted in the stock's value being pushed up to make it the highest among "purely NASH" companies. Among large pharma companies, Rahimi believes those with the strongest metabolic franchises, large R&D teams, and sales forces focused on endocrinologists, gastroenterologists, and hepatologists likely have eyes on NASH assets, listing Merck (MRK), AstraZeneca (AZN), Eli Lilly (LLY) and Novo Nordisk (NVO) as examples. The historical acquisition price for NASH assets ranges from $200M to $1.7B, but Rahimi argues that Madrigal "can set the highest NASH price tag yet," estimating a potential takeout valuation of $5.6B. Rahimi raised her price target on Madrigal shares to $400 from $210 and keeps a Buy rating on the stock.
05/31/18
SBSH
05/31/18
NO CHANGE
Target $100
SBSH
Buy
Amid investor questions, Citi reiterates $100 target on Tesaro
Citi analyst Robyn Karnauskas says she's been getting a lot of investor questions on Tesaro (TSRO) around the impact of Avastin approval on PARP use in first-line ovarian cancer, ahead of AstraZeneca's (AZN) Solo-1 data expected in the first half of 2018. After speaking to Tesaro's CEO, the analyst continues to be constructive on the quarter. The company believes that eventually Avastin will mostly be used in combinations, Karnauskas tells investors in a research note. She thinks Tesaro shares "will emerge" with crucial data expected in the latter half of the year. The analyst reiterates a Buy rating on the shares with a $100 price target.
05/30/18
JEFF
05/30/18
NO CHANGE
Target $48
JEFF
Hold
Tesaro risk/reward 'skewed toward downside,' says Jefferies
Jefferies analyst Eun Yang believes Tesaro's (TSRO) risk/reward is "skewed toward downside" into AstraZeneca's (AZN) Phase 3 ovarian cancer data for Lynparza . A discussion with a key opinion leader points to high bar for clinical/commercial success, Yang tells investors in a research note. She points out that Zejula in first-line ovarian cancer accounts for greater than 40% of her $48 price target for Tesaro. The analyst keeps a Hold rating on the shares.
GME GameStop
$13.34

-0.71 (-5.05%)

05/22/18
LOOP
05/22/18
NO CHANGE
Target $14
LOOP
Hold
GameStop LBO at 'sizable premium' would see attractive return, says Loop Capital
Loop Capital analyst Anthony Chukumba says that after years of underperformance, Gamestop now trades at "by far the lowest valuation multiple" in his entire coverage universe. Given that shareholders have become "more vocal", the analyst notes that a potential leveraged buyout at $19 per share could be a "feasible alternative" that could generate attractive returns, though he also adds that the absence of a "clearly defined exit strategy" make the prospects of such deal questionable. Chukumba keeps his Hold rating and $14 price target on Gamestop.
05/22/18
FBCO
05/22/18
NO CHANGE
Target $15
FBCO
Neutral
GameStop price target lowered to $15 from $20 at Credit Suisse
Credit Suisse analyst Seth Sigman lowered his price target for GameStop to $15 from $20 as it faces some difficult comparisons in the core business this year, continued uncertainty on the software side, and challenges in mobile. Further, the analyst notes he has yet to see clear signs that earnings can stabilize. Sigman reiterates a Neutral rating on the shares.
06/01/18
BARD
06/01/18
NO CHANGE
Target $14
BARD
Outperform
GameStop price target lowered to $14 from $18 at Baird
Baird analyst Colin Sebastian lowered his price target on GameStop to $14 from $18 following Q1 results. The analyst said the results were inline but were highlighted by continued strength in collectibles partially offset by anticipated weakness in new hardware, new software, pre-owned declines, and ongoing Tech Brands weakness. He said the current valuation is reflecting anticipated downside risk in the second half of the year. Sebastian maintained his Outperform rating and lowered his price target to $14 from $18 on GameStop shares.
06/01/18
BNCH
06/01/18
NO CHANGE
Target $10
BNCH
Sell
Benchmark, citing 'no confidence' in GameStop management, lowers target to $10
After GameStop reported Q1 sales, EBITDA and EPS that missed his estimates, Benchmark analyst Mike Hickey said he has "no confidence" in management and he believes the company is in "dire need of new leadership." The analyst, who thinks management is back end loading fiscal year performance expectations "while the hottest game in the world" is free-to-play, lowered his price target on GameStop shares to $10 from $12 and keeps a Sell rating on the stock.
GG Goldcorp
$14.19

-0.055 (-0.39%)

11/30/17
SBSH
11/30/17
DOWNGRADE
Target $13
SBSH
Sell
Barrick Gold downgraded to Sell from Buy at Citi
Citi analyst Alexander Hacking double downgraded Barrick Gold (ABX) to Sell from Buy and cut his price target for the shares to $13 from $20. The analyst cites the company's operating issues and potential for an upcoming reinvestment cycle. He remains "neutral to cautious" on the gold sector heading into 2018. Hacking this morning also upgraded Goldcorp (GG) to Buy and Agnico Eagle (AEM) to Neutral.
04/23/18
ADAM
04/23/18
UPGRADE
ADAM
Buy
Goldcorp upgraded to Buy from Hold at Canaccord
01/15/18
FBCO
01/15/18
UPGRADE
Target $19
FBCO
Outperform
Goldcorp upgraded to Outperform from Neutral at Credit Suisse
Credit Suisse analyst Anita Soni upgraded Goldcorp to Outperform and raised her price target for the shares to $19 from $15.50. The shares closed Friday up 45c, or 3%, to $14.35. Soni sees Goldcorp posting "attractive" growth over the next two years and believes its analyst day on January 16 will serve as a positive catalyst for the shares. The analyst views the company's valuation as attractive relative to peers.
11/30/17
SBSH
11/30/17
UPGRADE
Target $16
SBSH
Buy
Goldcorp upgraded to Buy from Neutral at Citi
Citi analyst Alexander Hacking upgraded Goldcorp to Buy and raised his price target for the shares to $16 from $15. The multi-year underperformance of the shares has reset investor expectations and "opened up value," Hacking tells investors i a research note. The analyst remains "neutral to cautious" on the gold sector heading into 2018.
XLP Consumer Staples Sector SPDR
$51.17

-0.175 (-0.34%)

DB Deutsche Bank
$11.38

-0.025 (-0.22%)

02/14/18
02/14/18
DOWNGRADE
Target $48

Hold
Luxoft downgraded to Hold on 'elongated turnaround' at Pivotal Research
As previously reported, Pivotal Research analyst Lou Miscioscia downgraded Luxoft (LXFT) to Hold from Buy, as he now expects most of FY19 to be "a struggle." He had expected the company's two biggest customers - namely Deutsche Bank (DB) and UBS (UBS) - to be about flat for FY19, but now they are suggested to be down 20% and 5%, respectively, Miscioscia said. Noting also that the company cut its FY18 guidance along with its Q3 report, the analyst lowered his price target on Luxoft to $48 from $70.
02/19/18
BOFA
02/19/18
UPGRADE
BOFA
Neutral
Deutsche Bank upgraded to Neutral from Underperform at BofA/Merrill
06/01/18
RBCM
06/01/18
DOWNGRADE
RBCM
Underperform
Deutsche Bank downgraded to Underperform from Sector Perform at RBC Capital
11/20/17
11/20/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Wal-Mart (WMT) downgraded to Neutral from Buy at Goldman Sachs with analyst Matthew Fassler sayign valuation following "powerful" share appreciation now reflects the company's progress in growing earnings. 2. Five Below (FIVE) downgraded to Hold from Buy at Loop Capital with analyst Anthony Chukumba citing valuation. 3. Live Nation (LYV) downgraded to In Line from Outperform at Evercore ISI with analyst David Joyce citing valuation. 4. Monster Beverage (MNST) downgraded to Negative from Neutral at Susquehanna with analyst Pablo Zuanic citing its high valuation, which he believes is misplaced due to assumptions about an offer from Coca-Cola (KO). 5. Deutsche Bank (DB) downgraded to Underperform from Market Perform at Keefe Bruyette. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

NWN

Northwest Natural Gas

$62.63

0.075 (0.12%)

, PCG

PG&E

$42.98

2.44 (6.02%)

18:17
06/22/18
06/22
18:17
06/22/18
18:17
Hot Stocks
Northwest Natural to sell Gill Ranch Storage to SENSA Holdings »

NW Natural (NWN)…

NWN

Northwest Natural Gas

$62.63

0.075 (0.12%)

PCG

PG&E

$42.98

2.44 (6.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

ORLY

O'Reilly Automotive

$285.90

-1.18 (-0.41%)

18:03
06/22/18
06/22
18:03
06/22/18
18:03
Hot Stocks
O'Reilly Automotive's O'Reilly sells 19,250 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SJI

South Jersey Industries

$33.15

0.02 (0.06%)

17:46
06/22/18
06/22
17:46
06/22/18
17:46
Hot Stocks
South Jersey Industries announces approval of Elizabethtown Gas purchase »

South Jersey Industries…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WAAS

AquaVenture

$15.36

0.12 (0.79%)

17:27
06/22/18
06/22
17:27
06/22/18
17:27
Hot Stocks
AquaVenture extends long-stop date for Ghana plant acquisition to September 30 »

AquaVenture announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NSANY

Nissan

$0.00

(0.00%)

17:22
06/22/18
06/22
17:22
06/22/18
17:22
Periodicals
Nissan chooses Thailand for hybrid's first export market, Nikkei reports »

Nissan has planned to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TROV

Trovagene

$0.81

-0.0068 (-0.83%)

17:22
06/22/18
06/22
17:22
06/22/18
17:22
Hot Stocks
Trovagene CEO William Welch resigns, Dr. Thomas Adams named interim CEO »

Trovagene announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVM

CEL-SCI

$3.26

0.005 (0.15%)

17:19
06/22/18
06/22
17:19
06/22/18
17:19
Syndicate
Breaking Syndicate news story on CEL-SCI »

CEL-SCI files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACM

Aecom

$33.49

-0.15 (-0.45%)

17:19
06/22/18
06/22
17:19
06/22/18
17:19
Hot Stocks
Aecom to compete for $148.5M U.S. Army contract »

AECOM-Baker JV, Bryan…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LMT

Lockheed Martin

$298.95

-1.39 (-0.46%)

17:17
06/22/18
06/22
17:17
06/22/18
17:17
Hot Stocks
Lockheed Martin awarded $175.3M U.S. Navy contract modification »

Lockheed Martin is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

LMT

Lockheed Martin

$298.95

-1.39 (-0.46%)

17:16
06/22/18
06/22
17:16
06/22/18
17:16
Hot Stocks
Lockheed Martin awarded $1.12B U.S. Air Force contract »

Lockheed Martin has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

XLE

Energy Select Sector SPDR

$75.21

1.59 (2.16%)

, XLU

Utilities SPDR

$50.75

0.36 (0.71%)

17:14
06/22/18
06/22
17:14
06/22/18
17:14
General news
Week ending ETF Scorecard: Utilities and Real Estate advance, Industrials slump »

S&P500 SECTORS:…

XLE

Energy Select Sector SPDR

$75.21

1.59 (2.16%)

XLU

Utilities SPDR

$50.75

0.36 (0.71%)

IYR

DJ US Real Estate Index Fund

$80.69

0.56 (0.70%)

XLP

Consumer Staples Sector SPDR

$51.62

0.42 (0.82%)

XLY

Consumer Discretionary Sector SPDR

$111.34

-0.15 (-0.13%)

XLB

S&P Select Materials SPDR

$58.49

0.79 (1.37%)

XLF

Financial Select Sector

$27.07

-0.145 (-0.53%)

XLV

Health Care Select Sector SPDR

$84.91

0.35 (0.41%)

XLK

Technology Select Sector SPDR

$70.78

-0.24 (-0.34%)

XLI

Industrial Select Sector SPDR

$72.59

0.22 (0.30%)

GLD

SPDR Gold Trust

$120.33

0.27 (0.22%)

SLV

iShares Silver Trust

$15.49

0.135 (0.88%)

USO

United States Oil Fund

$14.02

0.71 (5.33%)

UNG

United States Natural Gas Fund

$23.87

-0.24 (-1.00%)

HYG

iShares iBoxx $ High Yield Corporate Bond

$85.91

-0.015 (-0.02%)

LQD

iShares iBoxx $ Investment Grade Corporate Bond

$113.99

0.105 (0.09%)

TLT

iShares 20+ Year Treasury Bond Fund

$120.57

0.06 (0.05%)

IEF

iShares 7-10 Year Treasury Bond ETF

$102.11

0.03 (0.03%)

SHY

iShares 1-3 Year Treasury Bond

$83.30

0.005 (0.01%)

IWD

iShares Russell 1000 Value

$122.51

0.56 (0.46%)

IWF

iShares Russell 1000 Growth

$146.24

-0.2 (-0.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PFNX

Pfenex

$5.43

0.14 (2.65%)

17:01
06/22/18
06/22
17:01
06/22/18
17:01
Hot Stocks
Pfenex set to join Russell 2000 Index »

Pfenex announced it is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BXE

Bellatrix Exploration

$1.00

-0.0101 (-1.00%)

17:01
06/22/18
06/22
17:01
06/22/18
17:01
Syndicate
Breaking Syndicate news story on Bellatrix Exploration »

Bellatrix Exploration…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LOGI

Logitech

$44.24

0.25 (0.57%)

16:56
06/22/18
06/22
16:56
06/22/18
16:56
Initiation
Logitech initiated  »

Logitech initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PAGS

PagSeguro Digital

$30.35

0.925 (3.14%)

16:51
06/22/18
06/22
16:51
06/22/18
16:51
Hot Stocks
Breaking Hot Stocks news story on PagSeguro Digital »

Point72 Asset Management…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

APLS

Apellis

$21.75

-0.2 (-0.91%)

16:50
06/22/18
06/22
16:50
06/22/18
16:50
Conference/Events
Apellis to host research and development day »

Research and Development…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$274.75

0.47 (0.17%)

16:50
06/22/18
06/22
16:50
06/22/18
16:50
Periodicals
SEC investigates whether companies rounded up earnings, WSJ reports »

The U.S. Securites and…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$274.75

0.47 (0.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

THRM

Gentherm

$38.20

-0.75 (-1.93%)

16:45
06/22/18
06/22
16:45
06/22/18
16:45
Conference/Events
Gentherm to hold a strategic update »

Strategic Update for the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MGTX

MeiraGTx

$11.86

-0.97 (-7.56%)

16:43
06/22/18
06/22
16:43
06/22/18
16:43
Hot Stocks
Breaking Hot Stocks news story on MeiraGTx »

Perceptive Advisors…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDT

Medtronic

$86.80

0.51 (0.59%)

16:39
06/22/18
06/22
16:39
06/22/18
16:39
Conference/Events
Medtronic to hold an analyst and investor briefing »

In conjunction with the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

  • 25

    Jun

  • 26

    Jun

  • 12

    Jul

FOXA

21st Century Fox

$48.59

0.25 (0.52%)

, FOX

21st Century Fox

$48.28

0.31 (0.65%)

16:35
06/22/18
06/22
16:35
06/22/18
16:35
Hot Stocks
21st Century Fox extends CFO John Nallen's employment contract to 2021 »

On June 22, 21st Century…

FOXA

21st Century Fox

$48.59

0.25 (0.52%)

FOX

21st Century Fox

$48.28

0.31 (0.65%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FENC

Fennec

$10.97

0.5 (4.78%)

16:34
06/22/18
06/22
16:34
06/22/18
16:34
Hot Stocks
Breaking Hot Stocks news story on Fennec »

Opaleye Management…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SBBP

Strongbridge Biopharma

$6.20

-0.15 (-2.36%)

16:33
06/22/18
06/22
16:33
06/22/18
16:33
Hot Stocks
Breaking Hot Stocks news story on Strongbridge Biopharma »

Opaleye Management…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 26

    Jun

16:30
06/22/18
06/22
16:30
06/22/18
16:30
Options
Preliminary option volume of 16.8M today »

Preliminary option volume…

COOL

PolarityTE

$38.91

-0.09 (-0.23%)

16:28
06/22/18
06/22
16:28
06/22/18
16:28
Conference/Events
PolarityTE to hold a meeting »

Management hosts a Key…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 25

    Jun

  • 26

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.